Midi Health vs T2D.com
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Midi Health
Best for women in menopause / perimenopause with commercial insurance who want GLP-1 prescribing as part of a broader hormone + metabolic care plan, not as a standalone weight-loss productStarting at $128/mo
T2D.com
Best for diabetic GLP-1 accessStarting at $999/mo
Side-by-Side Comparison
| Feature | Midi Health | T2D.com |
|---|---|---|
| Overall Score | ✓7.0/10 | 6.1/10 |
| Starting Price | ✓$128/mo | $999/mo |
| Editorial Rating | ✓3.5 ★ /5 | 3.1 ★ /5 |
| Features | 4 features | ✓7 features |
| States Available | 0 | ✓1 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Midi Health
Pros
- ✓Nationwide availability in all 50 states (verified on the public homepage)
- ✓Accepts commercial insurance — differentiator vs most cash-pay-only GLP-1 telehealth
- ✓Menopause + metabolic health specialty framing — useful for women in the demographic where GLP-1 efficacy and weight regulation overlap most
- ✓Compounded semaglutide pricing starts at $127.90/mo for uninsured patients per the public pricing/insurance page
Cons
- ✗Does NOT accept Medicare, Medicaid, or Medi-Cal — eliminates roughly 40% of the insured US adult population
- ✗GLP-1 prescribing is clinician-discretionary inside a broader menopause care plan, NOT a guaranteed offering at intake — readers signing up purely for GLP-1 access may not get it
- ✗Menopause-focused — not the right fit for men or younger women whose primary need is weight loss
T2D.com
Pros
- ✓Built specifically for type 2 diabetic and pre-diabetic patients
- ✓Integrated service — prescriber, pharmacy, and delivery handled in one flow
- ✓Offers both compounded semaglutide and compounded tirzepatide
- ✓Temperature-controlled home delivery via UPS or FedEx
- ✓Ongoing prescriber monitoring and support included
Cons
- ✗No pricing published on the public website — must register to see costs
- ✗No states list published on the site
- ✗Newer brand with limited independent reviews
- ✗Compounded only — no brand-name Ozempic, Wegovy, or Mounjaro
Our Verdict
Midi Health edges out T2D.com with a higher overall score of 7.0/10 and is particularly strong for women in menopause / perimenopause with commercial insurance who want GLP-1 prescribing as part of a broader hormone + metabolic care plan, not as a standalone weight-loss product. T2D.com remains a solid alternative, especially if you're looking for diabetic GLP-1 access.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.